feed,title,long_url,short_url
Benzinga,Ocuphire's Nightblindness Candidate Meets Primary Endpoint In Phase 3 Study,https://benzinga.com/general/biotech/22/05/27297666/ocuphires-nightblindness-candidate-meets-primary-endpoint-in-phase-3-study,https://bit.ly/3MxpRLU
